Trecek Corporation incurs research and development costs of $685,000 in 2023,30 percent of which relate to development activities subsequent to IAS 36 criteria having been met that indicate an intangible asset has been created. The newly developed product is brought to market in January 2024 and is expected to generate sales revenue for 10 years. Assume that Trecek Corporation is a U.S.-based company that is issuing securties to foreign investors who require financial statements prepared in accordance with IFRS. Thus, adjustments to convert from U.S. GAAP to IFRS must be made. Ignore income taxes. Required: Q. Prepare journal entries for research and development costs for the years ending December 31, 2023, and December 31,2024. under (1) U.S. GAAP and (2) IFRS. b. Prepare journal entries that Trecek would moke on the December 31,2023, and December 31, 2024, conversion worksheets to convert US GAAP balances to IFRS Complete this question by entering your answers in the tabs below. Prepare joumal entries for research and development costs for the years ending December 31, 2023, and December 31, 2024, under (1) U.S. GAAP and (2) IFRS. Note: If no entry is required for a transaction/event, select "No journal entry required" in the first account field. 1 Record the research and development costs as per U.S. GAAP. 2. Record the research and development costs as per IRFS. 3 Record the amortization expense as per U.S. GAAP. 4 Record the amortization expense as per IFRS. Prepare joumal entries that Trecek would make on the December 31, 2023, and December 31, 2024, conversion worksheets to convert U.S. GAAP balances to IFRS. Note: If no entry is required for a transactionvevent, select "No journal entry required" in the first account field. 1 Record the conversion entry needed for the research and development costs for 12/31/23. 2 Record the conversion entry needed for the research and development costs for 12/31/24. 3 Record the conversion entry needed for the amortization expense for 12/31/24